Biogen to pull MS drug in Australia following encephalitus reports

Healthcare 2018-03-16 11:43 am By Cat Fredenburgh Melbourne

Please login to bookmark

Biogen said Thursday it will pull its multiple sclerosis drug Zinbryta in Australia, nearly two weeks after the biotech company issued a worldwide withdrawal of the drug following reports of encephalitus in Europe.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au